Oncotelic Therapeutics, Inc. (OTLC)
Q2-CY2026Q1-CY2026Q4-CY2025Q3-CY2025Q2-CY2025Q1-CY2025Q4-CY2024Q3-CY2024Q2-CY2024Q1-CY2024Q4-CY2023Q3-CY2023Q2-CY2023Q1-CY2023Q4-CY2022Q3-CY2022Q2-CY2022Q1-CY2022Q4-CY2021Q3-CY2021Q2-CY2021Q1-CY2021Q4-CY2020Q3-CY2020Q2-CY2020Q1-CY2020Q4-CY2019Q3-CY2019Q2-CY2019Q1-CY2019Q4-CY2018Q3-CY2018Q2-CY2018Q1-CY2018Q4-CY2017Q3-CY2017Q2-CY2017Q1-CY2017Q4-CY2016Q3-CY2016Q2-CY2016Q1-CY2016Q4-CY2015Q3-CY2015Q2-CY2015Q1-CY2015Q4-CY2014Q3-CY2014Q2-CY2014
Balance Sheet Date2025-Dec-312025-Sep-302025-Jun-302025-Mar-312024-Dec-312024-Sep-302024-Jun-302024-Mar-312023-Dec-312021-Mar-312020-Dec-312020-Sep-302020-Jun-302020-Mar-312019-Dec-312019-Sep-302019-Jun-302019-Mar-312018-Dec-312018-Sep-302018-Jun-302018-Mar-312017-Dec-312017-Sep-302017-Jun-302017-Mar-312016-Dec-312016-Sep-302016-Jun-302016-Mar-312015-Dec-312015-Sep-302015-Jun-302015-Mar-312014-Dec-312014-Sep-302014-Jun-30
Fiscal PeriodQ4-FY2025Q3-FY2025Q2-FY2025Q1-FY2025Q4-FY2024Q3-FY2024Q2-FY2024Q1-FY2024Q4-FY2023Q1-FY2021Q4-FY2020Q3-FY2020Q2-FY2020Q1-FY2020Q4-FY2019Q3-FY2019Q2-FY2019Q1-FY2019Q4-FY2018Q3-FY2018Q2-FY2018Q1-FY2018Q4-FY2017Q3-FY2017Q2-FY2017Q1-FY2017Q4-FY2016Q3-FY2016Q2-FY2016Q1-FY2016Q4-FY2015Q3-FY2015Q2-FY2015Q1-FY2015Q4-FY2014Q3-FY2014Q2-FY2014
Total Revenue0$70,000$0$0$1,400,000$340,855$0$0$0$0$0$
QoQ%(100.00%).00%(100.00%)310.73%.00%.00%.00%.00%
YoY%.00%
Cost Of Revenue0$0$0$0$0$0$0$0$0$0$0$
Gross Profit0$70,000$0$0$1,400,000$340,855$0$0$0$0$0$
Gross Margin100.00%100.00%100.00%
Operating Expenses2,528,560$490,973$65,969$101,100$31,454$3,280,757$96,582$167,222$113,463$55,522$6,321,904$264,116$2,037,882$3,331,987$1,616,273$1,386,160$2,989,502$1,243,096$930,713$1,161,005$976,063$154,603$214,033$153,308$795,000$2,436,000$3,540,000$3,896,000$3,970,000$3,475,000$3,262,000$3,670,000$3,352,000$3,978,000$3,599,000$3,328,000$2,777,000$2,645,000$3,453,000$3,924,000$
Operating Income(2,528,560$)(490,973$)(65,969$)(101,100$)(31,454$)(3,280,757$)(96,582$)(167,222$)(113,463$)14,478$(6,321,904$)(264,116$)(2,037,882$)(3,331,987$)(1,616,273$)13,840$(2,648,647$)(1,243,096$)(930,713$)(1,161,005$)(976,063$)(154,603$)(214,033$)(153,308$)(795,000$)(2,436,000$)(3,540,000$)(3,896,000$)(3,970,000$)(3,475,000$)(3,262,000$)(3,670,000$)(3,352,000$)(3,978,000$)(3,599,000$)(3,328,000$)(2,777,000$)(2,645,000$)(3,453,000$)(3,924,000$)
Operating Margin20.68%.99%(777.06%)
Interest Income10$0$0$123$1,000$3,000$5,000$7,000$1,000$2,000$7,000$12,000$14,000$22,000$26,000$29,000$28,000$12,000$7,000$5,000$3,000$2,000$2,000$1,000$
Interest Expenses234,709$394,278$520,906$383,088$331,459$137,089$1,148,351$660,961$60,413$28,105$
Income Before Tax250,293,099$(1,114,369$)210,449$(364,264$)(654,461$)(3,371,651$)(278,173$)(475,175$)(791,072$)41,061$(6,850,010$)(606,044$)(3,122,637$)(3,440,242$)(1,986,557$)582,091$(4,657,894$)(3,481,714$)(991,126$)(1,189,110$)(633,000$)(626,000$)(214,033$)(153,308$)(794,000$)(2,434,000$)(3,536,000$)(3,884,000$)(3,958,000$)(3,453,000$)(3,236,000$)(3,641,000$)(3,325,000$)(3,966,000$)(3,592,000$)(3,324,000$)(2,772,000$)(2,638,000$)(3,450,000$)(3,929,000$)
Tax Expenses
Net Income250,293,099$(1,114,369$)210,449$(364,264$)(654,461$)(3,371,651$)(278,173$)(475,175$)(791,072$)41,061$(6,850,010$)(606,044$)(3,122,637$)(3,440,242$)(1,986,557$)582,091$(4,657,894$)(3,481,714$)(991,126$)(1,189,110$)(633,000$)(626,000$)(214,033$)(153,308$)(794,000$)(2,434,000$)(3,536,000$)(3,884,000$)(3,958,000$)(3,453,000$)(3,236,000$)(3,641,000$)(3,325,000$)(3,966,000$)(3,592,000$)(3,324,000$)(2,772,000$)(2,638,000$)(3,450,000$)(3,929,000$)
Profit Margin58.66%41.58%(1,366.53%)
TTM(545.86%)
Earnings to Minority(54,958$)(67,004$)(67,407$)(65,548$)(53,527$)(67,165$)(68,336$)(66,499$)(55,089$)(74,248$)(93,010$)(80,625$)(319,557$)979,541$343,063$(471,397$)(603,206$)
Earnings to Common Shareholders250,348,057$(1,047,365$)277,856$(298,716$)(600,934$)(3,304,486$)(209,837$)(408,676$)(735,983$)115,309$(6,757,000$)(525,419$)(2,803,080$)(3,440,242$)(1,986,557$)582,091$(4,657,894$)(3,481,714$)(991,126$)(1,189,110$)(976,063$)(154,603$)(214,033$)(153,308$)(190,794$)(2,434,000$)(3,536,000$)(3,884,000$)(3,958,000$)(3,453,000$)(3,236,000$)(3,641,000$)(3,325,000$)(3,966,000$)(3,592,000$)(3,324,000$)(2,772,000$)(2,638,000$)(3,450,000$)(3,929,000$)
QoQ%24,002.66%(476.95%)193.02%50.29%81.82%(1,474.79%)48.65%44.47%(738.27%)101.71%(1,186.02%)18.52%(73.18%)(441.28%)112.50%(33.78%)(251.29%)16.65%(21.83%)(531.34%)27.77%(39.61%)19.65%92.16%31.17%8.96%1.87%(14.63%)(6.71%)11.12%(9.50%)16.16%(10.41%)(8.06%)(19.91%)(5.08%)23.54%12.19%(49.39%)
YoY%41,759.83%68.31%232.42%26.91%18.35%(2,965.77%)96.90%22.22%39.82%1.19%(100.43%)148.95%(377.21%)(2,152.04%)(363.07%)(675.64%)(411.58%)93.65%93.95%96.05%95.18%29.51%(9.27%)(6.67%)(19.04%)12.94%9.91%(9.54%)(19.95%)(50.34%)(4.12%)15.40%(5.40%)(25.80%)30.50%4.98%
Earnings Per Share, Basic0.57$0.00$0.00$0.00$0.00$(0.01$)0.00$0.00$0.00$0.00$(0.02$)0.00$(0.03$)(0.04$)(0.02$)0.01$(0.05$)(0.04$)(0.01$)(0.02$)(0.14$)0.01$(0.04$)(0.03$)(0.01$)(0.09$)(0.13$)(0.15$)(0.15$)(0.13$)(0.12$)(0.14$)(0.13$)(0.15$)(0.14$)(0.13$)(0.13$)(0.13$)(0.17$)(0.23$)
Earnings Per Share, Diluted0.00$0.00$0.00$(0.01$)0.00$0.00$0.00$0.00$(0.03$)(0.04$)(0.02$)0.01$(0.05$)(0.04$)(0.01$)(0.02$)(0.14$)0.01$(0.04$)(0.03$)(0.01$)(0.09$)(0.13$)(0.15$)(0.15$)(0.13$)(0.12$)(0.14$)(0.13$)(0.15$)(0.14$)(0.13$)(0.13$)(0.13$)(0.17$)(0.23$)
Unlevered FCF Per Share, Basic0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$(0.01$)(0.02$)(0.02$)0.00$0.00$(0.01$)(0.01$)(0.01$)(0.02$)0.00$(0.03$)0.14$(0.03$)(0.03$)(0.12$)(0.19$)
Unlevered FCF Per Share, Diluted0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$(0.01$)(0.02$)(0.02$)0.00$0.00$(0.01$)(0.01$)(0.01$)(0.02$)0.00$(0.03$)0.14$(0.03$)(0.03$)(0.12$)(0.19$)
Average Shares, Basic442,030,834426,435,213408,292,720407,423,329409,321,474407,289,888401,595,958399,378,572351,789,987397,777,882394,374,227392,359,38094,193,34890,365,12388,964,54988,152,40384,917,07392,997,08674,526,57965,384,4316,925,528-14,120,4676,068,7626,051,95326,545,00026,545,00026,545,00026,545,00026,545,00026,545,00026,545,00026,545,00026,545,00026,619,00026,545,00026,545,00021,095,00020,874,00020,705,00017,259,000
Average Shares, Diluted452,809,058407,423,329409,321,474407,289,888401,595,958399,378,572397,777,882392,359,38094,193,34883,780,82388,964,54994,736,70384,917,07392,997,08674,526,57965,384,4316,925,528-14,120,4676,068,7626,051,95326,545,00026,545,00026,545,00026,545,00026,545,00026,545,00026,545,00026,545,00026,545,00026,619,00026,545,00026,545,00021,095,00020,874,00020,705,00017,259,000
EBIT250,293,099$(1,114,369$)210,449$(364,264$)(654,461$)(3,371,651$)(278,173$)(240,466$)(791,072$)41,061$(6,850,010$)(211,766$)(2,601,731$)(3,057,154$)(1,655,098$)719,180$(3,509,543$)(2,820,753$)(930,713$)(1,161,005$)(633,000$)(626,000$)(214,033$)(153,308$)(794,000$)(2,434,000$)(3,536,000$)(3,884,000$)(3,958,000$)(3,453,000$)(3,236,000$)(3,641,000$)(3,325,000$)(3,966,000$)(3,592,000$)(3,324,000$)(2,772,000$)(2,638,000$)(3,450,000$)(3,929,000$)
EBITDA250,293,099$(1,114,369$)210,449$(364,264$)(654,461$)(3,371,651$)(278,173$)(240,466$)(791,072$)41,061$(6,850,010$)(211,766$)(2,601,731$)(3,057,154$)(1,655,098$)719,180$(3,509,543$)(2,820,753$)(930,713$)(1,161,005$)(633,000$)(626,000$)(214,033$)(153,308$)(794,000$)(2,434,000$)(3,536,000$)(3,884,000$)(3,958,000$)(3,453,000$)(3,236,000$)(3,641,000$)(3,325,000$)(3,966,000$)(3,592,000$)(3,324,000$)(2,772,000$)(2,638,000$)(3,450,000$)(3,929,000$)